Industry › BioTech

Press Releases

醫思健康管理層再度增持公司股份對集團發展前景充滿信心

Feb 28, 2022 18:30 HKT/SGT

Senior Management Further Increases Shareholdings in EC Healthcare With Strong Confidence in the Group's Future Development

Feb 28, 2022 18:29 HKT/SGT

Eisai: LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Approved in Japan for Radically Unresectable or Metastatic Renal Cell Carcinoma

Feb 25, 2022 16:26 HKT/SGT

乐普生物科技成功登陆香港交易所主板

Feb 23, 2022 18:13 HKT/SGT

樂普生物科技成功登陸香港交易所主板

Feb 23, 2022 18:12 HKT/SGT

Lepu Biopharma Co., Ltd. Successfully Listed on the Main Board of HKEX

Feb 23, 2022 18:11 HKT/SGT

Sirnaomics公布STP705治疗皮肤基底细胞癌临床II期中期数据

Feb 23, 2022 16:52 HKT/SGT

Sirnaomics公佈STP705治療皮膚基底細胞癌臨床II期中期數據

Feb 23, 2022 16:50 HKT/SGT

Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma

Feb 23, 2022 16:47 HKT/SGT

CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021

Feb 23, 2022 16:00 HKT/SGT

Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7%

Feb 23, 2022 16:00 HKT/SGT

联合医务免费视频问诊助新冠患者安心

Feb 23, 2022 15:38 HKT/SGT

聯合醫務免費視頻問診助新冠患者安心

Feb 23, 2022 15:37 HKT/SGT

UMP Healthcare Offers Free Telemedicine Service to COVID-19 Patients

Feb 23, 2022 15:36 HKT/SGT

MBMV invests in international bio-tech startup Arcensus GmbH

Feb 22, 2022 11:00 HKT/SGT

Alset Capital Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option

Feb 21, 2022 12:00 HKT/SGT

医思健康获纳入恒生综合指数及恒生港股通指数

Feb 18, 2022 21:12 HKT/SGT

醫思健康獲納入恒生綜合指數及恒生港股通指數

Feb 18, 2022 21:11 HKT/SGT

EC Healthcare Included in the Hang Seng Composite Index & Hang Seng Stock Connect Hong Kong Index

Feb 18, 2022 21:10 HKT/SGT

IND Application for SinoMab's First-in-Class Asthma Therapeutic Product SM17 Accepted by FDA

Feb 17, 2022 15:13 HKT/SGT